IESE (España)
-
The Rocky Mountain Institute: Making Ideas Real
Massa, Lorenzo; Rosenberg, MikeCase SM-1582-EDecision Analysis, Innovation and Change, StrategyRocky Mountain Institute is a U.S.-based organization that conducts research and demonstration projects in the area of sustainability in general and energy in particular. The case study charts its development over the last 20 years and explores whether or not it should expand beyond the United States.Starting at €8.20
-
The Clinton Economic Program
Canals, JordiCase ASE-297-EEconomicsThis case sets the ground for a discussion of the main problems of the US economy in the 1990s and the new economic plan designed by President Clinton.Starting at €8.20
-
El programa económico de Clinton
Canals, JordiCase ASE-297EconomicsEste caso prepara el terreno para una discusión de los principales problemas de la economía de Estados Unidos en los años noventa y el nuevo plan económico diseñado por el presidente Clinton.Starting at €8.20
-
La reducción de impuestos del presidente Kennedy
Canals, JordiCase ASE-208EconomicsEl caso permite discutir la efectividad de la política fiscal para estimular la actividad económica. [Es una versión abreviada y modificada del caso The Tax Cut of 1964 (ASE-24)].Starting at €8.20
-
The Rocky Mountain Institute: Reinventing the Think and Do Tank of the Future
Massa, Lorenzo; Rosenberg, MikeCase SM-1604-EInnovation and Change, StrategyIn 2007, Michael Potts was appointed CEO of the Rocky Mountain Institute (RMI). RMI is an independent, non-profit "think and do tank" with the mission of promoting the efficient and restorative use of resources. While the Institute is well-known for its outstanding research and innovative ideas, Michael Potts soon realized it needed a management culture and a new strategic focus. The case illustrates RMI's restructuring process and the challenges...Starting at €8.20
-
Glaxo: The acquisition of Wellcome
Canals, Jordi; Bardolet Urgellès, DavidCase ASE-386-EEconomicsThis case describes the changes in the world pharmaceutical industry in 1995 and presents the challenges for Glaxo (the leading European pharmaceutical firm) and the potential acquisition of Wellcome. This decision will differ from other acquisitions made by firms like Merck, oriented towards vertical integration and control over the distribution network. The main topics that the case covers are: industry analysis; value chain analysis; positioni...Starting at €8.20